X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

44% Predict Biotech Funding Recovery In 2024, Says Survey

Content Team by Content Team
31st March 2024
in Drug Development, News
RECOVERY

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The recent survey from GlobalData- The State of the Biopharmaceutical Industry 2024, went on to reveal that 44% of the healthcare industry professionals that were surveyed globally happen to be optimistic or very optimistic when it comes to the recovery of biotech funding in the coming 12 months. This optimism comes after a downturn in private biotech venture financing, which has been seen in 2022 and 2023.

Throughout 2023, funding was reduced by 43.2% as compared to 2022 and by 52.3% vis-à-vis 2021, all attributed to the macroeconomic pressures that happened to be causing investors to become more cautious and at the same time prioritize their existing portfolios.

As of now, 607 venture-backed companies that happen to be headquartered in the US are getting affected by the downturn in biotech funding, with more than 1,500 drugs at stake, including pre-clinical ones. Of the 607 venture-backed companies, almost a third have not gone on to raise any capital in the last three years.

As per GlobalData’s Pharma Intelligence Center Deals Database, venture financing when it comes to US-headquartered companies with innovator drugs happened to peak in 2021, by 104% to reach $20.7bn, which in turn went on to see many early-stage biotech’s going public that year with inflated valuations. But this happened to lead to overvalued biotech’s that were unable to give out any sort of milestone result, hence causing a decline when it comes to investor confidence as well as selectivity in the new investments. Moreover, recent challenges like high inflation, high interest rates, and geopolitical instability have also gone on to prompt investors to become more selective.

It is well to be noted that the biotech’s are indeed turning to parallel sources of funding, and in the same survey, 39% of the respondents went on to identify enhanced industry partnerships as the most effective step so as to mitigate a downturn within the biotech funding. Respondents within the APAC region preferred government incentives or even grants rather than going for private VC investors so as to tackle the funding downturn as compared to those across North America and Europe. In the US, NIH grant funding for private companies happened to report a total deal value elevation of 16.1% to $1.86bn from 2021 to 2022, as per GlobalData’s Pharma Intelligence Center Grants Database, thereby underscoring its significance in mitigating the gap when it comes to investments received from venture capital.

In spite of the challenges within the private biotech funding landscape, venture capital funding has been critical when it comes to sustaining biotech innovation. Due to a decline from record highs in 2021, venture capital funding has gone on to remain relatively resilient all across 2022. But the signs now look to be pointing towards a potential return to pre-pandemic levels. With access to alternative sources so as to secure capital, including elevated industry partnerships as well as government grants, in addition to a stabilizing market and also easing inflationary pressures, the outlook when it comes to future biotech investment looks promising.

Previous Post

Continuous Bioprocessing Impacts Modern Biopharma Production

Next Post

Building A Long-Lasting Future For The Biopharma Sector

Related Posts

Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Emerging Oral Small Molecule Drugs
Drug Development

Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
Next Post

Building A Long-Lasting Future For The Biopharma Sector

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In